AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2016
Mar 15, 2016
33510_dirs_2016-03-15_fb364e8a-ae13-4acf-8a70-3a74a672b659.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2016-03-11
Reporting Person: LAVOY THOMAS C (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-11 | Common Stock | P | 25005 | $0.88 | Acquired | 118528 | Direct |
| 2016-03-11 | Common Stock | P | 11701 | $0.9 | Acquired | 130229 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16